Add-back therapy for endometriosis in adolescents

被引：0

作者：

Lubianca, JN

Gordon, CM

Laufer, MR

机构：

[1] Childrens Hosp, Div Gynecol, Dept Surg, Boston, MA 02115 USA

[2] Childrens Hosp, Dept Med, Div Adolescent Young Adult Med & Endocrinol, Boston, MA 02115 USA

[3] Brigham & Womens Hosp, Dept Obstet & Gynecol, Div Reprod Endocrinol, Boston, MA 02115 USA

[4] Harvard Univ, Sch Med, Boston, MA USA

来源：

JOURNAL OF REPRODUCTIVE MEDICINE | 1998年 / 43卷 / 03期

关键词：

endometriosis; GnRH; GnRH agonists; adolescence; bone density; add-back therapy;

D O I：

暂无

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

OBJECTIVE: To review the impact of gonadotropin-releasing hormone agonists (GnRH-as) an bone mass in adolescents and options for GnRH-a with "add-back" for long-term therapy for adolescents with endometriosis Mot responding to conventional therapy. STUDY DESIGN: Literature research. RESULTS: The use of GnRH-a plus add-back therapy has not been specifically studied in the adolescent population, and thus the ideal dosage of add-back sar steroids for adolescents has not been delineated. CONCLUSION: GnRH-a plus add-back can be considered for usage in adolescents with endometriosis who are refractory to conventional therapy, but steroids due needed to determine the ideal dosage and long-term effects.

引用

页码：164 / 172

页数：9

共 50 条

[41] Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis: A Randomized Controlled Trial EDITORIAL COMMENT
DiVasta, Amy D.
Feldman, Henry A.
Gallagher, Jenny Sadler
Stokes, Natalie A.
Laufer, Marc R.
Hornstein, Mark D.
Gordon, Catherine M.
OBSTETRICAL & GYNECOLOGICAL SURVEY, 2015, 70 (11) : 693 - 694
[42] Effects of add-back therapy on bone mineral density and pyridinium crosslinks in patients with endometriosis treated with gonadotropin-releasing hormone agonists
Gnoth, C
Gödtke, K
Freundl, G
Godehardt, E
Kienle, E
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1999, 47 (01) : 37 - 41
[43] Estrogen 'add-back' and lipid profile during GnRH agonist (triptorelin) therapy
Al-Omari, WR
Nassir, UN
Izzat, B
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2001, 74 (01) : 61 - 62
[44] Medical oophorectomy with and without estrogen add-back therapy in the prevention of migraine headache
Martin, V
Wernke, S
Mandell, K
Zoma, W
Bean, J
Pinney, S
Liu, J
Ramadan, N
Rebar, R
HEADACHE, 2003, 43 (04): : 309 - 321
[45] Effects of combined GnRH receptor antagonist linzagolix and hormonal add-back therapy on vaginal bleeding-delayed add-back onset does not improve bleeding pattern
Pohl, Oliver
Marchand, Line
Bell, David
Gotteland, Jean-Pierre
REPRODUCTIVE SCIENCES, 2020, 27 (04) : 988 - 995
[46] Investigation of add-back effects in a segmented Clover detector
王华磊
宋立涛
赵维娟
刘忠侠
张玉虎
周小红
郭应祥
雷祥国
中国物理C, 2010, (03) : 379 - 382
[47] Low-dose add-back therapy during postoperative GnRH agonist treatment
Tsai, Hsiao-Wen
Wang, Peng-Hui
Huang, Ben-Shian
Twu, Nae-Fang
Yen, Ming-Shyen
Chen, Yi-Jen
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2016, 55 (01): : 55 - 59
[48] Long-Term Safety of Elagolix With Hormonal Add-Back Therapy in Women With Endometriosis-Associated Pain: 24-Month Results
Simon, James
Kim, Jin Hee
Thomas, James
Miller, Paul
Snabes, Michael
OBSTETRICS AND GYNECOLOGY, 2022, 139 : 25S - 26S
[49] The incidence and characteristics of uterine bleeding during postoperative GnRH agonist treatment combined with tibolone add-back therapy in endometriosis patients of reproductive age
Shin, So-Young
Min, Jung-Ae
Yoon, Byung-Koo
Bae, Duk Soo
Choi, Doo Seok
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2007, 133 (01): : 90 - 94
[50] Add-back therapy: Extending safety and efficacy of GnRH analogues in the gynecologic patient - Discussion
Genazzani, A
Surrey, ES
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1998, 45 : 34 - 34

← 1 2 3 4 5 →